Clinical trials are shifting from sites to homes, enabled by connected medical devices and digital health technologies. Wearables now allow passive, real-time data collection, improving adherence, recruitment, and patient experience while reducing burdens. The paper highlights best practices: align digital biomarkers and endpoints with study goals and regulations, ensure devices are user-friendly, gain regulatory clearance, and manage vendors with clear KPIs. Robust planning for logistics, biomedical waste, and data security is critical. Automated edit checks, synchronized data aggregation, and interim analyses safeguard data quality, creating patient-centric, efficient trials.

Join for free to read